首页|期刊导航|动物模型与实验医学（英文）|Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage Ⅰ-Ⅲ lung adenocarcinoma patients

Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage Ⅰ-Ⅲ lung adenocarcinoma patients

Xiao-Kai Zhan Xi-Kun Liu Sen Zhang Hong Chen

动物模型与实验医学（英文）2023，Vol.6Issue(5)：464-473,10.

动物模型与实验医学（英文）2023，Vol.6Issue(5)：464-473,10.DOI:10.1002/ame2.12355

Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage Ⅰ-Ⅲ lung adenocarcinoma patients

Xiao-Kai Zhan ¹Xi-Kun Liu ²Sen Zhang ²Hong Chen³

作者信息

1. Division of Oncology and Hematology,Beijing Chao-Yang Hospital,Capital Medical University,Beijing,P.R.China
2. State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,P.R.China
3. Pathology Department,Beijing Chao-Yang Hospital,Capital Medical University,Beijing,P.R.China
折叠

摘要

关键词

Chinese patients/ICOS/ICOSL/lung adenocarcinoma/prognostic factor

Key words

Chinese patients/ICOS/ICOSL/lung adenocarcinoma/prognostic factor

引用本文复制引用

Xiao-Kai Zhan,Xi-Kun Liu,Sen Zhang,Hong Chen..Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage Ⅰ-Ⅲ lung adenocarcinoma patients[J].动物模型与实验医学（英文）,2023,6(5):464-473,10.

基金项目

We appreciate the funding from the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(CIFMS,nos:2022-I2M-JB-011,2022-I2M-1-014),the National Natural Science Foundation of China(82293684),and the National Key R&D Program of China(2022YFA0806400). （CIFMS,nos:2022-I2M-JB-011,2022-I2M-1-014）

动物模型与实验医学（英文）

OACSCD

ISSN：2096-5451

访问量0

下载量0

段落导航